Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study

DOI Full Paper Access

214

Citations

21

References

2020

Year

Jonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, Enrique Grande, Jean‐Pierre Delord, Ronnie Shapira‐Frommer, Emily K. Bergsland, Manisha H. Shah, Marwan Fakih, Shunji Takahashi,

Clinical Cancer Research

Abstract

Pembrolizumab monotherapy showed limited antitumor activity and manageable safety in patients with previously treated advanced well-differentiated NETs.

References

	Year	Citations

Page 1